Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ZOLPIDEM TARTRATE USP, with a corresponding US DMF Number 18164.
Remarkably, this DMF maintains an Active status since its submission on March 14, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 31, 2013, and payment made on January 04, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II